Primary cold agglutinin-associated lymphoproliferative disease: A B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma

Haematologica

Volumn 99, Issue 3, 2014, Pages 497-504

  Randen, Ulla ^a,b   Trøen, Gunhild ^a   Tierens, Anne ^a   Steen, Chloé ^a   Warsame, Abdirashid ^a,b   Beiske, Klaus ^a   Tjønnfjord, Geir E ^a,b   Berentsen, Sigbjørn ^c,d   Delabie, Jan ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUGESUND HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD11 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD27 ANTIGEN; CD5 ANTIGEN; COLD AGGLUTININ; INTERFERON REGULATORY FACTOR 4; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BCL 6; X BOX BINDING PROTEIN 1; BCL6 PROTEIN, HUMAN; CRYOGLOBULIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DNA EXTRACTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; VERY ELDERLY; WALDENSTROEM MACROGLOBULINEMIA; BIOPSY; BONE MARROW; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNOLOGY; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; METABOLISM; MIDDLE AGED; PATHOLOGY; SPLEEN; WALDENSTROM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; CRYOGLOBULINS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MYELOID DIFFERENTIATION FACTOR 88; SPLEEN; WALDENSTROM MACROGLOBULINEMIA;

EID: 84895739667     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.091702     Document Type: Article

References (42)

1. Dacie SJ. The immune haemolytic anaemias: a century of exciting progress in understanding. Br J Haematol. 2001;114(4): 770-85.
2. Rosse WF, Adams JP. The variability of hemolysis in the cold agglutinin syndrome. Blood. 1980;56(3):409-16.
3. Rosse WF, Hillmen P, Schreiber AD. Immunemediated hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2004;48-62.
4. Issitt PD. I blood group system and its relationship to disease. J Med Lab Technol. 1968;25(1):1-6.
5. Berentsen S, Tjonnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev. 2012;26(3):107-15.
6. Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica. 2006;91(4):460-6.
7. Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol. 2011;4(6):607-18.
8. Berentsen S, Beiske K, Tjonnfjord GE. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. Hematology. 2007;12(5):361-70.
9. Dacie JV. Auto-immune haemolytic anaemia (AIHA): cold antibody syndromes I: idiopathic types: clinical presentation and haematological findings. In: Dacie JV, editor. The Haemolytic Anaemias. Churchill Livingstone; 1992. p. 210-39.
10. Hughey CT, Brewer JW, Colosia AD, Rosse WF, Corley RB. Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM. J Immunol. 1998;161(8):4091-7.
11. Zilow G, Kirschfink M, Roelcke D. Red-cell destruction in cold agglutinin disease. Infusionsther Transfusionsmed 1994;21(6): 410-5.
12. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol. 1992;149 (7):2337-44.
13. Bhat NM, Bieber MM, Spellerberg MB, Stevenson FK, Teng NN. Recognition of autoand exoantigens by V4-34 gene encoded antibodies. Scand J Immunol. 2000;51(2): 134-40.
14. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2004;103(8):2925-8.
15. Berentsen S, Randen U, Vagan AM, Hjorth-Hansen H, Vik A, Dalgaard J, et al. High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood. 2010;116(17):3180-4.
16. Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 2013;27(1):183-9.
17. Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med. 2012;367(9):826-33.
18. Sanchez ML, Almeida J, Vidriales B, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16(8):1460-9.
19. van Dongen JJ, Lhermitte L, Bottcher S, Almeida J, vand V, V, Flores-Montero J, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26(9):1908-75.
20. Spellerberg M, Chapman C, Hamblin T, Stevenson F. Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus. Ann NY Acad Sci. 1995; 764:427-32.
21. Zhang QY, Foucar K. Bone marrow involvement by Hodgkin and non-Hodgkin lymphomas. Hematol Oncol Clin North Am. 2009;23(4):873-902.
22. Swerdlow SH. WHO Classification of Tumours of Haematopoietic and Lymphoid tissue. Lyon: IARC; 2008.
23. Leleu X, Hunter ZR, Xu L, Roccaro AM, Moreau AS, Santos DD, et al. Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom macroglobulinemia. Br J Haematol. 2009;145 (1):59-63.
24. Natkunam Y, Warnke RA, Montgomery K, Falini B, van De RM. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol. 2001;14(7):686-94.
25. Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual Bcell origin and an expansion of polyclonal B cells in peripheral blood. Blood. 2004;104 (7):2134-42.
26. San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez ML, et al. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30(2):187-95.
27. Martin-Jimenez P, Garcia-Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sanchez ML et al. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Haematologica. 2007;92:635-642.
28. Varettoni M, Zibellini S, Capello D, Arcaini L, Rossi D, Pascutto C et al. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors. Leuk Lymphoma. 2013;54 (11):2485-9.
29. Owen RG. Developing diagnostic criteria in Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30(2):196-200.
30. Berentsen S. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia. Clin Lymphoma Myeloma. 2009;9(1):110-2.
31. Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M et al. Clinical characteristics and outcome of immunoglobulin M-related disorders. Clin Lymphoma. 2005;5(4):261-4.
32. Potter KN. Molecular characterization of cold agglutinins. Transfus Sci. 2000;22(1-2):113-9.
33. Pascual V, Victor K, Lelsz D, Spellerberg MB, Hamblin TJ, Thompson KM, et al. Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol. 1991;146(12):4385-91.
34. Silberstein LE, Jefferies LC, Goldman J, Friedman D, Moore JS, Nowell PC, et al. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood. 1991;78(9): 2372-86.
35. Potter KN, Hobby P, Klijn S, Stevenson FK, Sutton BJ. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol. 2002;169(7):3777-82.
36. Traverse-Glehen A, Verney A, Baseggio L, Felman P, Callet-Bauchu E, Thieblemont C, et al. Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin. Leukemia. 2007;21(8):1821-4.
37. Seifert M, Kuppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med. 2009;206(12):2659-69.
38. Milner EC, Anolik J, Cappione A, Sanz I. Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol. 2005;26(4):433-52.
39. Kuraoka M, Liao D, Yang K, Allgood SD, Levesque MC, Kelsoe G, et al. Activationinduced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. J Immunol. 2009;183(5):3237-48.
40. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004;104(12):3647-54.
41. Chng WJ, Chen J, Lim S, Chong SM, Kueh YK, Lee SH. Translocation (8;22) in cold agglutinin disease associated with B-cell lymphoma. Cancer Genet Cytogenet. 2004;152(1):66-9.
42. Michaux L, Dierlamm J, Wlodarska L, Criel A, Louwagie A, Ferrant A, et al. Trisomy 3q11-q29 is recurrently observed in B-cell non-Hodgkin's lymphomas associated with cold agglutinin syndrome. Ann Hematol. 1998;76(5):201-4.